- Home
- SARO vs HALO Comparison
SARO vs HALO Comparison
Compare SARO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SARO
- HALO
- Stock Information
- Founded
- SARO 1911
- HALO 1998
- Country
- SARO United States
- HALO United States
- Employees
- SARO N/A
- HALO N/A
- Industry
- SARO
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SARO
- HALO Health Care
- Exchange
- SARO NYSE
- HALO Nasdaq
- Market Cap
- SARO 9.3B
- HALO 7.4B
- IPO Year
- SARO 2024
- HALO N/A
- Fundamental
- Price
- SARO $28.16
- HALO $54.54
- Analyst Decision
- SARO Buy
- HALO Buy
- Analyst Count
- SARO 8
- HALO 9
- Target Price
- SARO $34.75
- HALO $63.56
- AVG Volume (30 Days)
- SARO 2.7M
- HALO 3.3M
- Earning Date
- SARO 05-12-2025
- HALO 05-06-2025
- Dividend Yield
- SARO N/A
- HALO N/A
- EPS Growth
- SARO N/A
- HALO 55.40
- EPS
- SARO 0.23
- HALO 3.76
- Revenue
- SARO $5,437,026,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- SARO $15.54
- HALO $25.77
- Revenue Next Year
- SARO $11.37
- HALO $18.01
- P/E Ratio
- SARO $120.17
- HALO $14.51
- Revenue Growth
- SARO 17.03
- HALO 25.64
- 52 Week Low
- SARO $21.31
- HALO $42.01
- 52 Week High
- SARO $34.38
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- SARO N/A
- HALO 44.48
- Support Level
- SARO N/A
- HALO $52.43
- Resistance Level
- SARO N/A
- HALO $54.26
- Average True Range (ATR)
- SARO 0.00
- HALO 3.42
- MACD
- SARO 0.00
- HALO -0.49
- Stochastic Oscillator
- SARO 0.00
- HALO 30.60
About SARO STANDARDAERO INC.
StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.